Biome Australia Ltd
ASX:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Butterfly Network Inc
NYSE:BFLY
|
US |
|
I
|
Irm Energy Ltd
NSE:IRMENERGY
|
IN |
Biome Australia Ltd
Total Liabilities & Equity
Biome Australia Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Total Liabilities & Equity
AU$12m
|
CAGR 3-Years
13%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Holista CollTech Ltd
ASX:HCT
|
Total Liabilities & Equity
AU$5.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
|
Bioxyne Ltd
ASX:BXN
|
Total Liabilities & Equity
AU$34.6m
|
CAGR 3-Years
94%
|
CAGR 5-Years
65%
|
CAGR 10-Years
33%
|
|
|
S
|
Skin Elements Ltd
ASX:SKN
|
Total Liabilities & Equity
AU$2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Total Liabilities & Equity
AU$116.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Total Liabilities & Equity
AU$47m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Biome Australia Ltd
Glance View
Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.
See Also
What is Biome Australia Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
12m
AUD
Based on the financial report for Jun 30, 2025, Biome Australia Ltd's Total Liabilities & Equity amounts to 12m AUD.
What is Biome Australia Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
44%
Over the last year, the Total Liabilities & Equity growth was 45%. The average annual Total Liabilities & Equity growth rates for Biome Australia Ltd have been 13% over the past three years , 44% over the past five years .
